Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.03x is 36% above its 2-year average of -1.61x, near the high end of its 2-year range (-4.91x–0.00x).
3.84% below its 12-month average of -0.99x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2025 (2025-12-31): -0.84x.
INTEREST COVERAGE RATIO
-1.03x
INTEREST COVERAGE RATIO AVG TTM
-0.99x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-3.84%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
+84.01%
vs the sector median at left
Jyong Biotech Ltd. Ordinary Shares
Market Cap
$153.58M
Interest Coverage Ratio
-1.03x
TTM Avg
-0.99x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$153.79M
Interest Coverage Ratio
-3.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$152.72M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$151.01M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$156.22M
Interest Coverage Ratio
N/A
TTM Avg
2247.41x
3Y Avg
1131.54x
5Y Avg
905.57x
Market Cap
$149.36M
Interest Coverage Ratio
-64.93x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$148.73M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$148.64M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$148.27M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jyong Biotech Ltd. Ordinary Shares (MENS) | $153.58M | -1.03x | -0.99x | N/A | N/A |
| Neuronetics, Inc. (STIM)vs › | $153.79M | -3.74x | N/A | N/A | N/A |
| Veraxa Biotech Holding AG (VRXA)vs › | $152.72M | N/A | N/A | N/A | N/A |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.01M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $156.22M | N/A | 2247.41x | 1131.54x | 905.57x |
| ALX Oncology Holdings Inc. (ALXO)vs › | $149.36M | -64.93x | N/A | N/A | N/A |
| Korsana Biosciences, Inc. (KRSA)vs › | $148.73M | N/A | N/A | N/A | N/A |
| Voyager Therapeutics, Inc. (VYGR)vs › | $148.64M | N/A | N/A | N/A | N/A |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.27M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $159.14M | -19.95x | 6.75x | 6.75x | 6.75x |
Interest Coverage
-1.0x
Debt/Equity
N/A
Current Ratio
0.45
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-12-31 | -0.84x |
| 2025-09-30 | -1.17x |
| 2025-06-30 | -1.96x |
| 2024-12-31 | 0.00x |
| 2024-09-30 | -1.89x |
| 2024-06-30 | 0.00x |
| 2024-03-31 | -2.15x |
| 2023-12-31 | -4.91x |
